Education
About Us
Working with TipRanks
Follow Us
FDLS - ETF AI Analysis
Top Page
Inspire Fidelis Multi Factor ETF (FDLS)
Rating:70Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid year-to-date gains, indicating strong overall momentum.
Sector Diversification
The fund is spread across multiple sectors, including Technology, Industrials, and Financials, reducing reliance on any single industry.
Healthy Top Holdings
Several top holdings, such as CytomX Therapeutics and ViaSat, have shown strong year-to-date performance, supporting the fund’s growth.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, offering little exposure to international markets.
Mixed Short-Term Performance
The fund’s one-month performance has been slightly negative, suggesting short-term volatility.
Above-Average Expense Ratio
The ETF’s expense ratio is higher than many comparable funds, which could reduce net returns for investors over time.
FDLS vs. SPDR S&P 500 ETF (SPY)
AUM117.41M
RegionNorth America
Expense Ratio0.69%
Beta1.06
IssuerInspire
Inception DateAug 23, 2022
Dividend Yield5.92%
Asset ClassEquity
Index TrackedWI Fidelis Multi-Cap, Multi-Factor Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume31,960
30 Day Avg. Volume17,670
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
42.21Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering101
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FDLS Summary
The Inspire Fidelis Multi Factor ETF (FDLS) is an investment fund that gives you exposure to a wide range of U.S. companies across different industries, such as technology, healthcare, and financials. It uses a strategy called multi-factor investing, which looks at factors like growth and value to build a balanced portfolio. Some well-known companies it includes are Western Digital and Newmont Mining. This ETF might appeal to investors who want diversification and a values-based approach to investing. However, it’s important to know that its performance can go up and down with the overall market, so it carries the risk of market fluctuations.
How much will it cost me?The Inspire Fidelis Multi Factor ETF (FDLS) has an expense ratio of 0.69%, which means you’ll pay $6.90 per year for every $1,000 invested. This is higher than average because it is actively managed, using a sophisticated multi-factor strategy to optimize returns and align with ethical investing principles.
What would affect this ETF?The Inspire Fidelis Multi Factor ETF (FDLS) could benefit from strong performance in the technology and industrials sectors, which make up a significant portion of its holdings, as well as continued interest in values-based investing. However, it may face challenges from economic slowdowns or rising interest rates, which could negatively impact smaller companies and growth-oriented investments. Additionally, its focus on U.S. markets means it is sensitive to domestic economic and regulatory changes.
FDLS Top 10 Holdings
The Inspire Fidelis Multi Factor ETF leans heavily on technology, with nearly a quarter of its portfolio tied to the sector, making it a key driver of performance. Stocks like Western Digital and NEXTracker are showing steady growth, benefiting from AI-driven markets and international expansion, respectively. Meanwhile, health care names like CytomX Therapeutics are rising on clinical progress, though operational risks remain. Consumer cyclical exposure, such as GigaCloud Technology, adds a touch of volatility but also growth potential. With its U.S.-focused holdings and diverse sector mix, the fund balances momentum with caution.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | 2.06% | $2.42M | $645.55M | 209.76% | 66 Neutral | |
| Western Digital | 1.52% | $1.79M | $54.70B | 121.16% | 79 Outperform | |
| Pediatrix Medical Group | 1.42% | $1.67M | $2.04B | 59.90% | 76 Outperform | |
| Viavi Solutions | 1.40% | $1.64M | $3.92B | 65.35% | 68 Neutral | |
| Argan | 1.37% | $1.61M | $4.94B | 138.46% | 75 Outperform | |
| Theravance Biopharma | 1.32% | $1.56M | $933.89M | 87.30% | 66 Neutral | |
| Rigel | 1.32% | $1.55M | $806.10M | 67.65% | 83 Outperform | |
| GigaCloud Technology, Inc. Class A | 1.28% | $1.51M | $1.44B | 63.06% | 80 Outperform | |
| TTM Technologies | 1.26% | $1.48M | $6.90B | 172.56% | 77 Outperform | |
| Carpenter Technology | 1.26% | $1.48M | $15.53B | 64.27% | 74 Outperform |
FDLS Technical Analysis
Positive
―
Price Trends
34.74
Positive
33.96
Positive
31.57
Positive
Market Momentum
0.28
Negative
59.15
Neutral
89.18
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FDLS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.90, equal to the 50-day MA of 34.74, and equal to the 200-day MA of 31.57, indicating a bullish trend. The MACD of 0.28 indicates Negative momentum. The RSI at 59.15 is Neutral, neither overbought nor oversold. The STOCH value of 89.18 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FDLS.
FDLS Peer Comparison
Comparison Results
Performance Comparison
FDLS
Inspire Fidelis Multi Factor ETF
35.79
3.94
12.37%
SYLD
Cambria Shareholder Yield ETF
―
―
―
PLDR
Putnam Sustainable Leaders ETF
―
―
―
ABFL
Fcf Us Quality Etf
―
―
―
PFM
Invesco Dividend Achievers ETF
―
―
―
AUSF
Global X Adaptive U.S. Factor ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents